456 related articles for article (PubMed ID: 16818784)
1. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
[TBL] [Abstract][Full Text] [Related]
2. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
3. The alpha 1 beta 1 and alpha E beta 7 integrins define a subset of dendritic cells in peripheral lymph nodes with unique adhesive and antigen uptake properties.
Pribila JT; Itano AA; Mueller KL; Shimizu Y
J Immunol; 2004 Jan; 172(1):282-91. PubMed ID: 14688336
[TBL] [Abstract][Full Text] [Related]
4. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes.
Brewig N; Kissenpfennig A; Malissen B; Veit A; Bickert T; Fleischer B; Mostböck S; Ritter U
J Immunol; 2009 Jan; 182(2):774-83. PubMed ID: 19124720
[TBL] [Abstract][Full Text] [Related]
5. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
Moll H; Fuchs H; Blank C; Röllinghoff M
Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
9. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis.
Ritter U; Osterloh A
Med Microbiol Immunol; 2007 Mar; 196(1):51-9. PubMed ID: 16786361
[TBL] [Abstract][Full Text] [Related]
10. Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania major.
Gray PM; Reiner SL; Smith DF; Kaye PM; Scott P
J Immunol; 2006 Jul; 177(2):925-33. PubMed ID: 16818747
[TBL] [Abstract][Full Text] [Related]
11. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
Lemos MP; Fan L; Lo D; Laufer TM
J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
[TBL] [Abstract][Full Text] [Related]
12. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
Lemos MP; Esquivel F; Scott P; Laufer TM
J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
[TBL] [Abstract][Full Text] [Related]
13. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
Johnson LM; Scott P
J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
[TBL] [Abstract][Full Text] [Related]
14. Cross-presenting dendritic cells are required for control of Leishmania major infection.
Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
[TBL] [Abstract][Full Text] [Related]
15. Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.
Muraille E; De Trez C; Pajak B; Torrentera FA; De Baetselier P; Leo O; Carlier Y
Infect Immun; 2003 May; 71(5):2704-15. PubMed ID: 12704145
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice.
Shah JA; Darrah PA; Ambrozak DR; Turon TN; Mendez S; Kirman J; Wu CY; Glaichenhaus N; Seder RA
J Exp Med; 2003 Jul; 198(2):281-91. PubMed ID: 12874261
[TBL] [Abstract][Full Text] [Related]
17. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
Abou Fakher FH; Rachinel N; Klimczak M; Louis J; Doyen N
J Immunol; 2009 Feb; 182(3):1386-96. PubMed ID: 19155485
[TBL] [Abstract][Full Text] [Related]
18. Dectin-1 Positive Dendritic Cells Expand after Infection with
Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
Front Immunol; 2018; 9():263. PubMed ID: 29535708
[TBL] [Abstract][Full Text] [Related]
19. Endogenous dendritic cells are required for amplification of T cell responses induced by dendritic cell vaccines in vivo.
Kleindienst P; Brocker T
J Immunol; 2003 Mar; 170(6):2817-23. PubMed ID: 12626531
[TBL] [Abstract][Full Text] [Related]
20. CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation.
Sato N; Ahuja SK; Quinones M; Kostecki V; Reddick RL; Melby PC; Kuziel WA; Ahuja SS
J Exp Med; 2000 Jul; 192(2):205-18. PubMed ID: 10899907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
